Pinnacle Bancorp Inc. Buys 50 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Pinnacle Bancorp Inc. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 50.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 150 shares of the company’s stock after acquiring an additional 50 shares during the period. Pinnacle Bancorp Inc.’s holdings in HCA Healthcare were worth $45,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in HCA. FMR LLC boosted its position in HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after buying an additional 2,397,883 shares during the period. Darsana Capital Partners LP grew its stake in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares during the last quarter. Meritage Group LP acquired a new position in HCA Healthcare during the 3rd quarter worth about $150,548,000. Holocene Advisors LP increased its stake in shares of HCA Healthcare by 210.6% in the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock valued at $124,691,000 after buying an additional 208,015 shares during the period. Finally, Nordea Investment Management AB lifted its stake in shares of HCA Healthcare by 29.7% in the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after acquiring an additional 193,075 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 1.0 %

Shares of NYSE:HCA opened at $309.26 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The business’s 50 day moving average is $318.49 and its 200 day moving average is $353.11. HCA Healthcare, Inc. has a 12-month low of $276.50 and a 12-month high of $417.14. The stock has a market cap of $78.34 billion, a price-to-earnings ratio of 13.89, a PEG ratio of 1.03 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Oppenheimer upped their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. KeyCorp dropped their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Truist Financial lowered their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $385.27.

Insider Buying and Selling at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.